What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Gene Therapy Market by Type (Germline Gene Therapy and Somatic Gene Therapy), Type of Vector, Disease Indication, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Publish Date: Mar, 2019
Report ID: 376052
Category: Healthcare
Pages: 0

$4700

Global gene therapy market is expected to reach USD 8.36 Million in 2017 to USD 38.41 Million by 2025 at a CAGR of 22.07% from 2018 to 2025. Increasing gene therapy innovations for cardiovascular and rare diseases treatment and significant investments in the field of gene-related research and development by various biopharmaceutical companies is increasing competition among market players which in turn is driving the growth in the assessment period.

Market Overview:

The genetic disorder occurs due to mutations in the gene, which results in incorrect protein production. Gene therapy is used to introduce a healthy gene into damaged cells. Mutated gene disrupts the protein function, and with the help of gene therapy, the function of that missing protein can be restored. Gene therapy is exclusively being used by the researchers for the treatment of various diseases such as HIV, Cancer, Parkinson’s disease, hemophilia and even immune deficiencies through various approaches. Increasing funding for R&D activities relating to gene therapy and an increase in awareness regarding gene therapy are the major factors propelling the growth of the market.

Report Description:

The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The gene therapy market is analyzed by value (USD Million).
The study delivers a comprehensive analysis of the global gene therapy market by type, type of vector and disease indication and regions.
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
Porter’s Five Forces model is used to recognize the competitive scenario in the global Gene Therapy market. This report incorporates the industry analysis which is focused on providing an extensive view of the gene therapy market.
The study also includes attractiveness analysis of type, type of vector and disease indication, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
The report provides company profile of the key players operating in the Gene Therapy market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

Increasing innovations in the field of gene therapy for cardiovascular and rare diseases treatment
Growing awareness about the ability of gene therapy
Increasing adoption in the treatment of several genetic disorders especially cancer, heart diseases, AIDS and cystic fibrosis
The rise in incidence rates of different types of cancers

Restraints:

Adverse immune responses related to treatment
Concerns regarding unethical use of gene therapy

Opportunities:

High demand from developing economies

Challenges:

Lack of skilled professionals
The high cost associated with the treatment

Global Gene Therapy Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The gene therapy market is segmented by type, type of vector and disease indication.

The type segment is classified into germline gene therapy and somatic gene therapy.
Type of vector segment is divided into the viral vector and non-viral vector. The key element of gene therapy is the delivery of a modified gene or functioning gene. Viral vector held the largest market share and was valued around USD 4.89 in 2017. Delivery systems deliver functioning gene to intended cell target through modified viruses several viruses such as Adeno-associated virus, retrovirus, and lentivirus are modified in labs for gene therapy drugs.
Disease Indication segment is classified into cardio vascular diseases, cancer, genetic disorders, neuro disorders, infectious diseases, and others. The cancer segment held the largest market share of around 41.37% in 2017. This growth can be attributed to a high number of pipeline products in the past. The rising prevalence of cancer is also contributing to the growth of the segment.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region dominated the global gene therapy market and held the largest market share of 58.31% in 2017 whereas the Asia Pacific is expected to attain the highest growth in the forecast period.

North America region is expected to dominate the market due to a large number of clinical trials conducting in the region, and an increasing number of gene therapy treatment centers in the region are driving the growth of the market in the region. For instance, in 2018, the U.S government approved USD 3 billion for The National Institutes of Health research funds.
The Asia Pacific is expected to register the highest growth in the forecast period. The rising number of population prone to various chronic diseases and offering better solutions to the patients at lower costs are major factors for growth. For instance, in 2017, National Cancer Center Japan (NCC) and Toray Industries, Inc. developed a new method that could detect thirteen different cancer types with a single drop of blood.

Global Gene Therapy Market Competitive Analysis:

Major players operating in the gene therapy market are Spark Therapeutics LLC, Bluebird Bio, UniQure N.V., Juno Therapeutics, GlaxoSmithKline, Chiesi Farmaceutici S.p.A., Bristol Myer’s Squibb, Celgene Corporation, Human Stem Cell Institute, Voyager Therapeutics, Shire Plc, Sangamo Biosciences, Dimension Therapeutics, and others. There are very few drugs in the market approved by various regulatory bodies across the globe. For instance, in 2016, GlaxoSmithKline received approval of European drug regulatory authority for drug “Strimvelis” for the treatment of ADA-SCID.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global gene therapy market on the basis of below mentioned segments:

Global Gene Therapy Market, By Type:

Germline Gene Therapy
Somatic Gene Therapy

Global Gene Therapy Market, By Type of Vector:

Viral Vectors
- Retrovirus
- Adenovirus
- Adeno-associated virus
- Vaccinia virus
- Herpes simplex virus
- Others
Non-Viral Vectors
- Injection of Naked DNA
- Lipofection
- Others

Global Gene Therapy Market, By Disease Indication:

Cardio Vascular Diseases
Infectious Diseases
Genetic Disorders
Neuro Disorders
Cancer
Others

Global Gene Therapy Market, By Regions:

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Sweden
- Netherlands
- U.K.
- Italy
- Spain
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Colombia
- Rest of South America
The Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

Request Sample Request for Customization

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market attractiveness analysis by type
4.3.2. Market attractiveness analysis by type of vector
4.3.3. Market attractiveness analysis by disease indication
4.3.4. Market attractiveness analysis by region
4.4. Industry Trends

5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing Innovations in the Field of Gene Therapy for Cardiovascular and Rare Diseases Treatment
5.2.2. Growing Awareness about the Ability of Gene Therapy
5.2.3. Increasing Adoption in the Treatment of Several Genetic Disorders Especially Cancer, Heart Diseases, Aids and Cystic Fibrosis
5.2.4. Rise in Incidence Rates of Different Types of Cancers
5.3. Restraints
5.3.1. Adverse Immune Responses Related to Treatment
5.4. Opportunities
5.4.1. High Demand from Emerging Economies
5.4.2. Increase in Products Approval
5.5. Challenges
5.5.1. High Cost Associated with the Treatment

6. Global Gene Therapy Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Germline Gene Therapy
6.3. Somatic Gene Therapy

7. Global Gene Therapy Market Analysis and Forecast, By Type of Vector
7.1. Segment Overview
7.2. Viral Vectors
7.2.1. Retrovirus
7.2.2. Adenovirus
7.2.3. Adeno-associated virus
7.2.4. Vaccinia virus
7.2.5. Herpes simplex virus
7.2.6. Others
7.3. Non-Viral Vectors
7.3.1. Injection of Naked DNA
7.3.2. Lipofection
7.3.3. Others

8. Global Gene Therapy Market Analysis and Forecast, By Disease Indication
8.1. Segment Overview
8.2. Cardio Vascular Diseases
8.3. Infectious Diseases
8.4. Genetic Disorders
8.5. Neuro Disorders
8.6. Cancer
8.7. Others

9. Global Gene Therapy Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. Sweden
9.3.4. Netherlands
9.3.5. U.K.
9.3.6. Italy
9.3.7. Spain
9.3.8. Turkey
9.3.9. Switzerland
9.3.10. Belgium
9.3.11. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Singapore
9.4.7. Malaysia
9.4.8. Thailand
9.4.9. Indonesia
9.4.10. Philippines
9.4.11. Rest of Asia-Pacific
9.5. South America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Colombia
9.5.4. Rest of South America
9.6. Middle East and Africa
9.6.1. Saudi Arabia
9.6.2. UAE
9.6.3. Egypt
9.6.4. Nigeria
9.6.5. South Africa
9.6.6. Rest of Middle East and Africa

10. Global Gene Therapy Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in the Gene Therapy Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions

11. Company Profiles
11.1. Spark Therapeutics LLC
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Bluebird Bio
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. UniQure N.V.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Juno Therapeutics
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Chiesi Farmaceutici S.p.A
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. GlaxoSmithKline
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Bristol Myer’s Squibb
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Celgene Corporation
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Human Stem Cell Institute
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Voyager Therapeutics
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. Shire Plc
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Sangamo Biosciences
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
11.13. Dimension Therapeutics
11.13.1. Business Overview
11.13.2. Company Snapshot
11.13.3. Company Market Share Analysis
11.13.4. Company Product Portfolio
11.13.5. Recent Developments
11.13.6. SWOT Analysis

List of Table
1. Global Gene Therapy Market, By Type, 2015–2025 (USD Million)
2. Global Germline Gene Therapy Market, By Region, 2015–2025 (USD Million
3. Global Somatic Gene Therapy Market, By Region, 2015–2025 (USD Million)
4. Global Gene Therapy Market, By Type of Vector, 2015–2025 (USD Million)
5. Global Gene Therapy Market, By Viral Vectors, 2015–2025 (USD Million)
6. Global Viral Vectors Gene Therapy Market, By Region, 2015–2025 (USD Million)
7. Global Gene Therapy Market, By Non-Viral Vectors, 2015–2025 (USD Million)
8. Global Non-Viral Vectors Gene Therapy Market, By Region, 2015–2025 (USD Million)
9. Global Gene Therapy Market, By Disease Indication, 2015–2025 (USD Million)
10. Global Cardio Vascular Diseases Gene Therapy Market, By Region, 2015–2025 (USD Million)
11. Global Infectious Diseases Gene Therapy Market, By Region, 2015–2025 (USD Million)
12. Global Genetic Disorders Gene Therapy Market, By Region, 2015–2025 (USD Million)
13. Global Neuro Disorders Gene Therapy Market, By Region, 2015–2025 (USD Million)
14. Global Cancer Gene Therapy Market, By Region, 2015–2025 (USD Million)
15. Global Others Gene Therapy Market, By Region, 2015–2025 (USD Million)
16. Global Gene Therapy Market, By Region, 2015–2025 (USD Million)
17. North America Gene Therapy Market, By Type, 2015–2025 (USD Million)
18. North America Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
19. North America Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
20. U.S. Gene Therapy Market, By Type, 2015–2025 (USD Million)
21. U.S. Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
22. U.S. Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
23. Canada Gene Therapy Market, By Type, 2015–2025 (USD Million)
24. Canada Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
25. Canada Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
26. Mexico Gene Therapy Market, By Type, 2015–2025 (USD Million)
27. Mexico Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
28. Mexico Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
29. Europe Gene Therapy Market, By Type, 2015–2025 (USD Million)
30. Europe Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
31. Europe Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
32. Germany Gene Therapy Market, By Type, 2015–2025 (USD Million)
33. Germany Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
34. Germany Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
35. France Gene Therapy Market, By Type, 2015–2025 (USD Million)
36. France Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
37. France Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
38. Sweden Gene Therapy Market, By Type, 2015–2025 (USD Million)
39. Sweden Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
40. Sweden Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
41. Netherlands Gene Therapy Market, By Type, 2015–2025 (USD Million)
42. Netherlands Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
43. Netherlands Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
44. U.K. Gene Therapy Market, By Type, 2015–2025 (USD Million)
45. U.K. Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
46. U.K. Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
47. Italy Gene Therapy Market, By Type, 2015–2025 (USD Million)
48. Italy Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
49. Italy Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
50. Spain Gene Therapy Market, By Type, 2015–2025 (USD Million)
51. Spain Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
52. Spain Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
53. Turkey Gene Therapy Market, By Type, 2015–2025 (USD Million)
54. Turkey Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
55. Turkey Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
56. Switzerland Gene Therapy Market, By Type, 2015–2025 (USD Million)
57. Switzerland Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
58. Switzerland Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
59. Belgium Gene Therapy Market, By Type, 2015–2025 (USD Million)
60. Belgium Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
61. Belgium Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
62. Asia Pacific Gene Therapy Market, By Type, 2015–2025 (USD Million)
63. Asia Pacific Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
64. Asia Pacific Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
65. Japan Gene Therapy Market, By Type, 2015–2025 (USD Million)
66. Japan Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
67. Japan Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
68. China Gene Therapy Market, By Type, 2015–2025 (USD Million)
69. China Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
70. China Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
71. India Gene Therapy Market, By Type, 2015–2025 (USD Million)
72. India Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
73. India Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
74. South Korea Gene Therapy Market, By Type, 2015–2025 (USD Million)
75. South Korea Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
76. South Korea Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
77. Australia Gene Therapy Market, By Type, 2015–2025 (USD Million)
78. Australia Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
79. Australia Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
80. Singapore Gene Therapy Market, By Type, 2015–2025 (USD Million)
81. Singapore Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
82. Singapore Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
83. Malaysia Gene Therapy Market, By Type, 2015–2025 (USD Million)
84. Malaysia Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
85. Malaysia Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
86. Thailand Gene Therapy Market, By Type, 2015–2025 (USD Million)
87. Thailand Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
88. Thailand Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
89. Indonesia Gene Therapy Market, By Type, 2015–2025 (USD Million)
90. Indonesia Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
91. Indonesia Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
92. Philippines Gene Therapy Market, By Type, 2015–2025 (USD Million)
93. Philippines Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
94. Philippines Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
95. South America Gene Therapy Market, By Type, 2015–2025 (USD Million)
96. South America Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
97. South America Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
98. Brazil Gene Therapy Market, By Type, 2015–2025 (USD Million)
99. Brazil Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
100. Brazil Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
101. Argentina Gene Therapy Market, By Type, 2015–2025 (USD Million)
102. Argentina Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
103. Argentina Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
104. Colombia Gene Therapy Market, By Type, 2015–2025 (USD Million)
105. Colombia Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
106. Colombia Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
107. Middle East and Africa Gene Therapy Market, By Type, 2015–2025 (USD Million)
108. Middle East and Africa Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
109. Middle East and Africa Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
110. Saudi Arabia Gene Therapy Market, By Type, 2015–2025 (USD Million)
111. Saudi Arabia Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
112. Saudi Arabia Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
113. UAE Gene Therapy Market, By Type, 2015–2025 (USD Million)
114. UAE Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
115. UAE Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
116. Egypt Gene Therapy Market, By Type, 2015–2025 (USD Million)
117. Egypt Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
118. Egypt Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
119. Nigeria Gene Therapy Market, By Type, 2015–2025 (USD Million)
120. Nigeria Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
121. Nigeria Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)
122. South Africa Gene Therapy Market, By Type, 2015–2025 (USD Million)
123. South Africa Gene Therapy Market, By Vector Type, 2015–2025 (USD Million)
124. South Africa Gene Therapy Market, By Disease Indication 2015–2025 (USD Million)

List of Figures
1. Global Gene Therapy Market Segmentation
2. Gene Therapy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Gene Therapy Market attractiveness analysis by Type
9. Global Gene Therapy Market attractiveness analysis by Vector Type
10. Global Gene Therapy Market attractiveness analysis by Disease Indication
11. Global Gene Therapy Market attractiveness analysis by Region
12. Global Gene Therapy Market: Dynamics
13. Global Gene Therapy Market Share by Type (2017 & 2025)
14. Global Gene Therapy Market Share by Vector Type (2017 & 2025)
15. Global Gene Therapy Market Share by Disease Indication (2017 & 2025)
16. Global Gene Therapy Market Share by Regions (2017 & 2025)
17. Global Gene Therapy Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!